CVD Risk Reduction and Lipid Management - 52

Meta-Analysis: Effects of Nicotinic Acid
Carotid Intima Media Thickness

Study ARBITER-6-HALTS Thoenes M et al ARBITER-2 CLAS

N 97 30 78 39

Treatment Mean (SD) -12 (36) -5 (11) 14 (104) -12 (20)

N 111 15 71 39

Control Mean SD -1 (31) 9 (12) 44 (100) 12 (20)

WMD (fixed) 95% Cl

WMD (fixed) 95% Cl -12 (-21, -2) -14 (-21, -7) -30 (-63, -3) -25 (-34, -16) -17 (-22, -12)

Total Test for heterogeneity: P = 0.13, I2 = 47.4% Test for overall effect: P < 0.0001 -100 -50 0 50
Annual change, μm/y

100

E. Bruckert et al, Atherosclerosis 210 (2010) 353-361



CVD Risk Reduction and Lipid Management

Table of Contents for the Digital Edition of CVD Risk Reduction and Lipid Management

CVD Risk Reduction and Lipid Management - 3
CVD Risk Reduction and Lipid Management - 5
CVD Risk Reduction and Lipid Management - 6
CVD Risk Reduction and Lipid Management - 7
CVD Risk Reduction and Lipid Management - 8
CVD Risk Reduction and Lipid Management - 9
CVD Risk Reduction and Lipid Management - 10
CVD Risk Reduction and Lipid Management - 11
CVD Risk Reduction and Lipid Management - 12
CVD Risk Reduction and Lipid Management - 13
CVD Risk Reduction and Lipid Management - 14
CVD Risk Reduction and Lipid Management - 15
CVD Risk Reduction and Lipid Management - 16
CVD Risk Reduction and Lipid Management - 17
CVD Risk Reduction and Lipid Management - 18
CVD Risk Reduction and Lipid Management - 19
CVD Risk Reduction and Lipid Management - 20
CVD Risk Reduction and Lipid Management - 21
CVD Risk Reduction and Lipid Management - 22
CVD Risk Reduction and Lipid Management - 23
CVD Risk Reduction and Lipid Management - 24
CVD Risk Reduction and Lipid Management - 25
CVD Risk Reduction and Lipid Management - 26
CVD Risk Reduction and Lipid Management - 27
CVD Risk Reduction and Lipid Management - 28
CVD Risk Reduction and Lipid Management - 29
CVD Risk Reduction and Lipid Management - 30
CVD Risk Reduction and Lipid Management - 31
CVD Risk Reduction and Lipid Management - 32
CVD Risk Reduction and Lipid Management - 33
CVD Risk Reduction and Lipid Management - 34
CVD Risk Reduction and Lipid Management - 35
CVD Risk Reduction and Lipid Management - 36
CVD Risk Reduction and Lipid Management - 37
CVD Risk Reduction and Lipid Management - 38
CVD Risk Reduction and Lipid Management - 39
CVD Risk Reduction and Lipid Management - 40
CVD Risk Reduction and Lipid Management - 41
CVD Risk Reduction and Lipid Management - 42
CVD Risk Reduction and Lipid Management - 43
CVD Risk Reduction and Lipid Management - 44
CVD Risk Reduction and Lipid Management - 45
CVD Risk Reduction and Lipid Management - 46
CVD Risk Reduction and Lipid Management - 47
CVD Risk Reduction and Lipid Management - 48
CVD Risk Reduction and Lipid Management - 49
CVD Risk Reduction and Lipid Management - 50
CVD Risk Reduction and Lipid Management - 51
CVD Risk Reduction and Lipid Management - 52
CVD Risk Reduction and Lipid Management - 53
CVD Risk Reduction and Lipid Management - 54
CVD Risk Reduction and Lipid Management - 55
CVD Risk Reduction and Lipid Management - 56
CVD Risk Reduction and Lipid Management - 57
CVD Risk Reduction and Lipid Management - 58
CVD Risk Reduction and Lipid Management - 59
CVD Risk Reduction and Lipid Management - 60
CVD Risk Reduction and Lipid Management - 61
CVD Risk Reduction and Lipid Management - 62
CVD Risk Reduction and Lipid Management - 63
CVD Risk Reduction and Lipid Management - 64
CVD Risk Reduction and Lipid Management - 65
CVD Risk Reduction and Lipid Management - 66
https://www.nxtbookmedia.com